Download Axols free white paper - "Induced Pluripotent Stem Cells: recapitulating disease to facilitate drug discovery" Understand more about how iPSC-derived cells can improve any drug development research program by supplying a physiologically relevant model, which is capable of representing a disease population. This enables research in multiple stages of the development pipeline. This white paper comprises cases wherein iPSC-derived cells have been utilized for target identification, target validation, lead optimization and safety testing, as a means of reducing failure rates of drug candidates.